| Literature DB >> 25686036 |
Xiaoling Chen1, Yanliu Luo2, Bo Zhou3, Zhiqing Huang4, Gang Jia5, Guangmang Liu6, Hua Zhao7, Zhouping Yang8, Ruinan Zhang9.
Abstract
Akirin2 plays an important role in skeletal myogenesis. In this study, we found that porcine Akirin2 (pAkirin2) mRNA level was significantly higher in fast extensor digitorum longus (EDL) and longissimus lumborum (LL) muscles than in slow soleus (SOL) muscle of pigs. Overexpression of pAkirin2 increased the number of myosin heavy chain (MHC)-positive cells, indicating that pAkirin2 promoted myoblast differentiation. We also found that overexpression of pAkirin2 increased the mRNA expressions of MHCI and MHCIIa and decreased the mRNA expression of MHCIIb. Myocyte enhancer factor 2 (MEF2) and nuclear factor of activated T cells (NFAT) are the major downstream effectors of calcineurin. Here we also observed that the mRNA expressions of MEF2C and NFATc1 were notably elevated by pAkirin2 overexpression. Together, our data indicate that the role of pAkirin2 in modulating MHCI and MHCIIa expressions may be achieved through calcineurin/NFATc1 signaling pathway.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25686036 PMCID: PMC4346940 DOI: 10.3390/ijms16023996
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Relative Akirin2 mRNA expression in different types of muscle tissues of pigs. Total RNA from slow soleus (SOL), longissimus lumborum (LL) and extensor digitorum longus (EDL) muscles of three healthy Duroc × Landrace × Yorkshire (DLY) pigs was used to perform the real-time quantitative PCR. Samples were performed in duplicate. The amount of Akirin2 mRNA was normalized to the amount of pβ-actin mRNA. Data were presented as means ± SE (n = 3), in arbitrary units. * p < 0.05, *** p < 0.001.
Figure 2Effect of pAkirin2 on myoblast differentiation. C2C12 myoblasts were seeded in a 24-well plate at 1 × 104 cells/well. The cells were transfected with 0.5 µg/well of the plasmid pcDNA3.1(+)-pAkirin2 or the empty vector pcDNA3.1(+) when they reached ~90% confluence and induced to differentiate for 5 days before analysis. Myosin heavy chain (MHC) expression was analyzed by immunofluorescence microscopy (DAPI staining also shown). The images are representative of the results obtained from two independent experiments. Magnification: ×100.
Figure 3Effect of pAkirin2 on MHC isoform expression in C2C12 myotubes. C2C12 myoblasts were cultured and transfected as in Figure 2. Two days after the transfection, the mRNA levels of MHCI, MHCIIa and MHCIIb were determined using real-time quantitative PCR. Samples were performed in duplicate. The amount of MHCI, MHCIIa and MHCIIb mRNA were normalized to the amount of GAPDH mRNA and mβ-actin mRNA. Data were presented as means ± SE (n = 3). ** p < 0.01.
Figure 4Effect of pAkirin2 on oxidative muscle fiber gene expression in C2C12 myotubes. C2C12 myoblasts were cultured and transfected as in Figure 2. After a transfection of 4 and 8 days, the mRNA levels of MEF2C, NFATc1 and MCIP1.4 were determined by real-time quantitative PCR. Samples were performed in duplicate. The amount of MEF2C, NFATc1 and MCIP1.4 mRNA were normalized to the amount of GAPDH mRNA and mβ-actin mRNA. Data were presented as means ± SE (n = 3). ** p < 0.01, *** p < 0.001.
List of genes, primer sequences, GenBank accession numbers, and product sizes in this study.
| Gene Name | Primer | Sequence | GenBank Accession No. | Product Size (bp) |
|---|---|---|---|---|
| Forward | 5'-CTTCTACAGGCCTGGGCTTAC-3' | 128 | ||
| Reverse | 5'-CTCCTTCTCAGACTTCCGCAG-3' | |||
| Forward | 5'-TTCCAGAAGCCTAAGGTGGTC-3' | 94 | ||
| Reverse | 5'-GCCAGCCAGTGATGTTGTAAT-3' | |||
| Forward | 5'-CTTGTCTGACTCAAGCCTGCC-3' | 158 | ||
| Reverse | 5'-TCGCTCCTTTTCAGACTTCCG-3' | |||
| Forward | 5'-GATGGGACTGGATTATCGC-3' | 154 | ||
| Reverse | 5'-GCACAAGATGAGTATGCGG-3' | |||
| Forward | 5'-CCGTTGGCTGGAAACAAG-3' | 153 | ||
| Reverse | 5'-GGTCACTCTCACACACGTGG-3' | |||
| Forward | 5'-AATAACATGCGAGCCATCATC-3' | 109 | ||
| Reverse | 5'-TCACCCTGGTGTTCTTCCTC-3' | |||
| Forward | 5'-GATCTCCGCGTTCTTATCCC-3' | 91 | ||
| Reverse | 5'-CCAATGACTGAGCCGACTG-3' | |||
| Forward | 5'-AGGGCATCTTGGGCTACAC-3' | 211 | ||
| Reverse | 5'-TGGTCCAGGGTTTCTTACTCC-3' | |||
| Forward | 5'-CCTTCCTTCTTGGGTATGGA-3' | 88 | ||
| Reverse | 5'-GGTCTTTACGGATGTCAACG-3' | |||
| Forward | 5'-CCACGAAACTACCTTCAACTCC-3' | 132 | ||
| Reverse | 5'-GTGATCTCCTTCTGCATCCTGT-3' |